comparemela.com
Home
Live Updates
FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVE : comparemela.com
FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVE
/PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced new data from the PARTNER 3 trial demonstrating continued low rates of all-cause mortality,...
Related Keywords
,
Edwards Lifesciences
,
Larry Wood
,
Prnewswire Edwards Lifesciences
,
Edwards Lifesciences Corporation
,
Facebook
,
Twitter
,
Youtube
,
Linkedin
,
Exchange Commission
,
Cardiovascular Research Foundation
,
Securities Exchange
,
Instagram
,
Transcatheter Cardiovascular Therapeutics
,
New England Journal
,
Martin Leon
,
Columbia University Irving Medical Center
,
Chairman Emeritus
,
Cardiovascular Research
,
Securities Act
,
Securities Exchange Act
,
comparemela.com © 2020. All Rights Reserved.